ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Generic Drugs Market Report & Forecast 2023-2029
Published Date: 2023-11-23
|
Report Code: QYRE-Auto-24L15545
Home | Market Reports
Global and India Generic Drugs Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Generic Drugs Market Report & Forecast 2023-2029

Code: QYRE-Auto-24L15545
Report
2023-11-23
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
TEVA
Novartis
Novartis AG
Sandoz Inc
Novartis (Sandoz)
Mylan NV
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin Ltd
Dr. Reddy's
Apotex
Cipla Ltd
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Pharmaniaga Berhad
Hovid Berhad
Duopharma Biotech
Kotra Pharma
HOE Pharmaceutical
Y.S.P. Industries

and India Generic Drugs Market Size

The global Generic Drugs revenue was US$ 313470 million in 2022 and is forecast to a readjusted size of US$ 551330 million by 2029 with a CAGR of 8.3% during the review period (2023-2029).

and India Generic Drugs Market

and India Generic Drugs Market

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
In India, the Generic Drugs revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.
Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.
North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.
This report focuses on global and India Generic Drugs market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Generic Drugs will continue to grow rapidly in the future.
Global Generic Drugs Scope and Market Size
Generic Drugs market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Generic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Generic Drugs market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Generic Drugs Market Report

Report Metric Details
Report Name and India Generic Drugs Market
Forecasted market size in 2029 US$ 551330 million
CAGR 8.3%
Forecasted years 2023 - 2029
Segment by Type
  • Prescription
  • Non-Prescription Drugs
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi, Aurobindo, Lupin, Dr. Reddy's, Apotex, Cipla, ENDO (Par Pharmaceutical), Stada Arzneimittel, Krka Group, Nichi-Iko Pharmaceutical, Valeant, Zydus Cadila, Hikma, Pharmaniaga Berhad, Hovid Berhad, Duopharma Biotech, Kotra Pharma, HOE Pharmaceutical, Y.S.P. Industries
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Generic Drugs Market size in 2029?

Ans: The and India Generic Drugs Market size in 2029 will be US$ 551330 million.

What is the Teva, Mylan, Sun Pharmaceutical, Aspen share in and India Generic Drugs Market?

Ans: Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.

What is the and India Generic Drugs Market share by region?

Ans: Following North America, Europe is the second largest consumption place with the consumption market share of 18%. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Generic Drugs Market report?

Ans: The main players in the and India Generic Drugs Market are Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi, Aurobindo, Lupin, Dr. Reddy's, Apotex, Cipla, ENDO (Par Pharmaceutical), Stada Arzneimittel, Krka Group, Nichi-Iko Pharmaceutical, Valeant, Zydus Cadila, Hikma, Pharmaniaga Berhad, Hovid Berhad, Duopharma Biotech, Kotra Pharma, HOE Pharmaceutical, Y.S.P. Industries

What are the Application segmentation covered in the and India Generic Drugs Market report?

Ans: The Applications covered in the and India Generic Drugs Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the and India Generic Drugs Market report?

Ans: The Types covered in the and India Generic Drugs Market report are Prescription, Non-Prescription Drugs

1 Study Coverage
1.1 Generic Drugs Product Introduction
1.2 Global Generic Drugs Outlook 2018 VS 2022 VS 2029
1.2.1 Global Generic Drugs Market Size for the Year 2018-2029
1.2.2 India Generic Drugs Market Size for the Year 2018-2029
1.3 Generic Drugs Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India Generic Drugs in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Generic Drugs Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 Generic Drugs Market Dynamics
1.4.1 Generic Drugs Industry Trends
1.4.2 Generic Drugs Market Drivers
1.4.3 Generic Drugs Market Challenges
1.4.4 Generic Drugs Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Generic Drugs by Type
2.1 Generic Drugs Market Segment by Type
2.1.1 Prescription
2.1.2 Non-Prescription Drugs
2.2 Global Generic Drugs Market Size by Type (2018, 2022 & 2029)
2.3 Global Generic Drugs Market Size by Type (2018-2029)
2.4 India Generic Drugs Market Size by Type (2018, 2022 & 2029)
2.5 India Generic Drugs Market Size by Type (2018-2029)
3 Generic Drugs by Application
3.1 Generic Drugs Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Generic Drugs Market Size by Application (2018, 2022 & 2029)
3.3 Global Generic Drugs Market Size by Application (2018-2029)
3.4 India Generic Drugs Market Size by Application (2018, 2022 & 2029)
3.5 India Generic Drugs Market Size by Application (2018-2029)
4 Global Generic Drugs Competitor Landscape by Company
4.1 Global Generic Drugs Market Size by Company
4.1.1 Global Key Companies of Generic Drugs, Ranked by Revenue (2022)
4.1.2 Global Generic Drugs Revenue by Player (2018-2023)
4.2 Global Generic Drugs Concentration Ratio (CR)
4.2.1 Generic Drugs Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Generic Drugs in 2022
4.2.3 Global Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Generic Drugs Head office and Area Served
4.4 Global Key Players of Generic Drugs, Product and Application
4.5 Global Key Players of Generic Drugs, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Generic Drugs Market Size by Company
4.7.1 Key Players of Generic Drugs in India, Ranked by Revenue (2022)
4.7.2 India Generic Drugs Revenue by Players (2021, 2022 & 2023)
5 Global Generic Drugs Market Size by Region
5.1 Global Generic Drugs Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Generic Drugs Market Size by Region (2018-2029)
5.2.1 Global Generic Drugs Market Size by Region: 2018-2023
5.2.2 Global Generic Drugs Market Size by Region (2024-2029)
6 Americas
6.1 Americas Generic Drugs Market Size YoY Growth 2018-2029
6.2 Americas Generic Drugs Market Size by Type
6.2.1 Americas Generic Drugs Market Size by Type (2018-2023)
6.2.2 Americas Generic Drugs Market Size by Type (2024-2029)
6.2.3 Americas Generic Drugs Market Share by Type (2018-2029)
6.3 Americas Generic Drugs Market Size by Application
6.3.1 Americas Generic Drugs Market Size by Application (2018-2023)
6.3.2 Americas Generic Drugs Market Size by Application (2024-2029)
6.3.3 Americas Generic Drugs Market Share by Application (2018-2029)
6.4 Americas Generic Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Generic Drugs Market Size YoY Growth 2018-2029
7.2 EMEA Generic Drugs Market Size by Type
7.2.1 EMEA Generic Drugs Market Size by Type (2018-2023)
7.2.2 EMEA Generic Drugs Market Size by Type (2024-2029)
7.2.3 EMEA Generic Drugs Market Share by Type (2018-2029)
7.3 EMEA Generic Drugs Market Size by Application
7.3.1 EMEA Generic Drugs Market Size by Application (2018-2023)
7.3.2 EMEA Generic Drugs Market Size by Application (2024-2029)
7.3.3 EMEA Generic Drugs Market Share by Application (2018-2029)
7.4 EMEA Generic Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Generic Drugs Market Size YoY Growth 2018-2029
8.2 China Generic Drugs Market Size by Type
8.2.1 China Generic Drugs Market Size by Type (2018-2023)
8.2.2 China Generic Drugs Market Size by Type (2024-2029)
8.2.3 China Generic Drugs Market Share by Type (2018-2029)
8.3 China Generic Drugs Market Size by Application
8.3.1 China Generic Drugs Market Size by Application (2018-2023)
8.3.2 China Generic Drugs Market Size by Application (2024-2029)
8.3.3 China Generic Drugs Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Generic Drugs Market Size YoY Growth 2018-2029
9.2 APAC Generic Drugs Market Size by Type
9.2.1 APAC Generic Drugs Market Size by Type (2018-2023)
9.2.2 APAC Generic Drugs Market Size by Type (2024-2029)
9.2.3 APAC Generic Drugs Market Share by Type (2018-2029)
9.3 APAC Generic Drugs Market Size by Application
9.3.1 APAC Generic Drugs Market Size by Application (2018-2023)
9.3.2 APAC Generic Drugs Market Size by Application (2024-2029)
9.3.3 APAC Generic Drugs Market Share by Application (2018-2029)
9.4 APAC Generic Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Teva
10.1.1 Teva Company Details
10.1.2 Teva Business Overview
10.1.3 Teva Generic Drugs Introduction
10.1.4 Teva Revenue in Generic Drugs Business (2018-2023)
10.1.5 Teva Recent Development
10.2 Novartis - Sandoz
10.2.1 Novartis - Sandoz Company Details
10.2.2 Novartis - Sandoz Business Overview
10.2.3 Novartis - Sandoz Generic Drugs Introduction
10.2.4 Novartis - Sandoz Revenue in Generic Drugs Business (2018-2023)
10.2.5 Novartis - Sandoz Recent Development
10.3 Mylan
10.3.1 Mylan Company Details
10.3.2 Mylan Business Overview
10.3.3 Mylan Generic Drugs Introduction
10.3.4 Mylan Revenue in Generic Drugs Business (2018-2023)
10.3.5 Mylan Recent Development
10.4 Sun Pharmaceutical
10.4.1 Sun Pharmaceutical Company Details
10.4.2 Sun Pharmaceutical Business Overview
10.4.3 Sun Pharmaceutical Generic Drugs Introduction
10.4.4 Sun Pharmaceutical Revenue in Generic Drugs Business (2018-2023)
10.4.5 Sun Pharmaceutical Recent Development
10.5 Aspen
10.5.1 Aspen Company Details
10.5.2 Aspen Business Overview
10.5.3 Aspen Generic Drugs Introduction
10.5.4 Aspen Revenue in Generic Drugs Business (2018-2023)
10.5.5 Aspen Recent Development
10.6 Fresenius Kabi
10.6.1 Fresenius Kabi Company Details
10.6.2 Fresenius Kabi Business Overview
10.6.3 Fresenius Kabi Generic Drugs Introduction
10.6.4 Fresenius Kabi Revenue in Generic Drugs Business (2018-2023)
10.6.5 Fresenius Kabi Recent Development
10.7 Pfizer (Hospira)
10.7.1 Pfizer (Hospira) Company Details
10.7.2 Pfizer (Hospira) Business Overview
10.7.3 Pfizer (Hospira) Generic Drugs Introduction
10.7.4 Pfizer (Hospira) Revenue in Generic Drugs Business (2018-2023)
10.7.5 Pfizer (Hospira) Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Details
10.8.2 Sanofi Business Overview
10.8.3 Sanofi Generic Drugs Introduction
10.8.4 Sanofi Revenue in Generic Drugs Business (2018-2023)
10.8.5 Sanofi Recent Development
10.9 Aurobindo
10.9.1 Aurobindo Company Details
10.9.2 Aurobindo Business Overview
10.9.3 Aurobindo Generic Drugs Introduction
10.9.4 Aurobindo Revenue in Generic Drugs Business (2018-2023)
10.9.5 Aurobindo Recent Development
10.10 Lupin
10.10.1 Lupin Company Details
10.10.2 Lupin Business Overview
10.10.3 Lupin Generic Drugs Introduction
10.10.4 Lupin Revenue in Generic Drugs Business (2018-2023)
10.10.5 Lupin Recent Development
10.11 Dr. Reddy's
10.11.1 Dr. Reddy's Company Details
10.11.2 Dr. Reddy's Business Overview
10.11.3 Dr. Reddy's Generic Drugs Introduction
10.11.4 Dr. Reddy's Revenue in Generic Drugs Business (2018-2023)
10.11.5 Dr. Reddy's Recent Development
10.12 Apotex
10.12.1 Apotex Company Details
10.12.2 Apotex Business Overview
10.12.3 Apotex Generic Drugs Introduction
10.12.4 Apotex Revenue in Generic Drugs Business (2018-2023)
10.12.5 Apotex Recent Development
10.13 Cipla
10.13.1 Cipla Company Details
10.13.2 Cipla Business Overview
10.13.3 Cipla Generic Drugs Introduction
10.13.4 Cipla Revenue in Generic Drugs Business (2018-2023)
10.13.5 Cipla Recent Development
10.14 ENDO (Par Pharmaceutical)
10.14.1 ENDO (Par Pharmaceutical) Company Details
10.14.2 ENDO (Par Pharmaceutical) Business Overview
10.14.3 ENDO (Par Pharmaceutical) Generic Drugs Introduction
10.14.4 ENDO (Par Pharmaceutical) Revenue in Generic Drugs Business (2018-2023)
10.14.5 ENDO (Par Pharmaceutical) Recent Development
10.15 Stada Arzneimittel
10.15.1 Stada Arzneimittel Company Details
10.15.2 Stada Arzneimittel Business Overview
10.15.3 Stada Arzneimittel Generic Drugs Introduction
10.15.4 Stada Arzneimittel Revenue in Generic Drugs Business (2018-2023)
10.15.5 Stada Arzneimittel Recent Development
10.16 Krka Group
10.16.1 Krka Group Company Details
10.16.2 Krka Group Business Overview
10.16.3 Krka Group Generic Drugs Introduction
10.16.4 Krka Group Revenue in Generic Drugs Business (2018-2023)
10.16.5 Krka Group Recent Development
10.17 Nichi-Iko Pharmaceutical
10.17.1 Nichi-Iko Pharmaceutical Company Details
10.17.2 Nichi-Iko Pharmaceutical Business Overview
10.17.3 Nichi-Iko Pharmaceutical Generic Drugs Introduction
10.17.4 Nichi-Iko Pharmaceutical Revenue in Generic Drugs Business (2018-2023)
10.17.5 Nichi-Iko Pharmaceutical Recent Development
10.18 Valeant
10.18.1 Valeant Company Details
10.18.2 Valeant Business Overview
10.18.3 Valeant Generic Drugs Introduction
10.18.4 Valeant Revenue in Generic Drugs Business (2018-2023)
10.18.5 Valeant Recent Development
10.19 Zydus Cadila
10.19.1 Zydus Cadila Company Details
10.19.2 Zydus Cadila Business Overview
10.19.3 Zydus Cadila Generic Drugs Introduction
10.19.4 Zydus Cadila Revenue in Generic Drugs Business (2018-2023)
10.19.5 Zydus Cadila Recent Development
10.20 Hikma
10.20.1 Hikma Company Details
10.20.2 Hikma Business Overview
10.20.3 Hikma Generic Drugs Introduction
10.20.4 Hikma Revenue in Generic Drugs Business (2018-2023)
10.20.5 Hikma Recent Development
10.21 Pharmaniaga Berhad
10.21.1 Pharmaniaga Berhad Company Details
10.21.2 Pharmaniaga Berhad Business Overview
10.21.3 Pharmaniaga Berhad Generic Drugs Introduction
10.21.4 Pharmaniaga Berhad Revenue in Generic Drugs Business (2018-2023)
10.21.5 Pharmaniaga Berhad Recent Development
10.22 Hovid Berhad
10.22.1 Hovid Berhad Company Details
10.22.2 Hovid Berhad Business Overview
10.22.3 Hovid Berhad Generic Drugs Introduction
10.22.4 Hovid Berhad Revenue in Generic Drugs Business (2018-2023)
10.22.5 Hovid Berhad Recent Development
10.23 Duopharma Biotech
10.23.1 Duopharma Biotech Company Details
10.23.2 Duopharma Biotech Business Overview
10.23.3 Duopharma Biotech Generic Drugs Introduction
10.23.4 Duopharma Biotech Revenue in Generic Drugs Business (2018-2023)
10.23.5 Duopharma Biotech Recent Development
10.24 Kotra Pharma
10.24.1 Kotra Pharma Company Details
10.24.2 Kotra Pharma Business Overview
10.24.3 Kotra Pharma Generic Drugs Introduction
10.24.4 Kotra Pharma Revenue in Generic Drugs Business (2018-2023)
10.24.5 Kotra Pharma Recent Development
10.25 HOE Pharmaceutical
10.25.1 HOE Pharmaceutical Company Details
10.25.2 HOE Pharmaceutical Business Overview
10.25.3 HOE Pharmaceutical Generic Drugs Introduction
10.25.4 HOE Pharmaceutical Revenue in Generic Drugs Business (2018-2023)
10.25.5 HOE Pharmaceutical Recent Development
10.26 Y.S.P. Industries
10.26.1 Y.S.P. Industries Company Details
10.26.2 Y.S.P. Industries Business Overview
10.26.3 Y.S.P. Industries Generic Drugs Introduction
10.26.4 Y.S.P. Industries Revenue in Generic Drugs Business (2018-2023)
10.26.5 Y.S.P. Industries Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
FEATURED COMPANIES
TEVA
Novartis
Novartis AG
Sandoz Inc
Novartis (Sandoz)
Mylan NV
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin Ltd
Dr. Reddy's
Apotex
Cipla Ltd
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Pharmaniaga Berhad
Hovid Berhad
Duopharma Biotech
Kotra Pharma
HOE Pharmaceutical
Y.S.P. Industries
List of Tables
    Table 1. Generic Drugs Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
    Table 2. Generic Drugs Market Trends
    Table 3. Generic Drugs Market Drivers
    Table 4. Generic Drugs Market Challenges
    Table 5. Generic Drugs Market Restraints
    Table 6. Global Generic Drugs Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Generic Drugs Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Generic Drugs Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Generic Drugs Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Companies of Generic Drugs, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Generic Drugs Revenue by Player, (US$ Million), 2018-2023
    Table 12. Global Generic Drugs Revenue Share by Player, 2018-2023
    Table 13. Global Generic Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drugs as of 2022)
    Table 15. Global Key Players of Generic Drugs, Headquarters and Area Served
    Table 16. Global Key Players of Generic Drugs, Product and Application
    Table 17. Global Key Players of Generic Drugs, Date of Enter into This Industry
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Key Players of Generic Drugs in India, Ranked by Revenue (2022) & (US$ Million)
    Table 20. India Generic Drugs Revenue by Players, (US$ Million), 2021, 2022 & 2023
    Table 21. India Generic Drugs Revenue Share by Players, 2021, 2022 & 2023
    Table 22. Global Generic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 23. Global Generic Drugs Market Size by Region (2018-2023) & (US$ Million)
    Table 24. Global Generic Drugs Market Size Forecast by Region (2024-2029) & (US$ Million)
    Table 25. Americas Generic Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Americas Generic Drugs Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Americas Generic Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Americas Generic Drugs Market Size by Application (2024-2029) & (US$ Million)
    Table 29. Americas Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 30. Americas Generic Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 31. Americas Generic Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 32. EMEA Generic Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 33. EMEA Generic Drugs Market Size by Type (2024-2029) & (US$ Million)
    Table 34. EMEA Generic Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 35. EMEA Generic Drugs Market Size by Application (2024-2029) & (US$ Million)
    Table 36. EMEA Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. EMEA Generic Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 38. EMEA Generic Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 39. China Generic Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 40. China Generic Drugs Market Size by Type (2024-2029) & (US$ Million)
    Table 41. China Generic Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 42. China Generic Drugs Market Size by Application (2024-2029) & (US$ Million)
    Table 43. China Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. APAC Generic Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 45. APAC Generic Drugs Market Size by Type (2024-2029) & (US$ Million)
    Table 46. APAC Generic Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 47. APAC Generic Drugs Market Size by Application (2024-2029) & (US$ Million)
    Table 48. APAC Generic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 49. APAC Generic Drugs Market Size by Region (2018-2023) & (US$ Million)
    Table 50. APAC Generic Drugs Market Size by Region (2024-2029) & (US$ Million)
    Table 51. Teva Company Details
    Table 52. Teva Business Overview
    Table 53. Teva Generic Drugs Product
    Table 54. Teva Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 55. Teva Recent Development
    Table 56. Novartis - Sandoz Company Details
    Table 57. Novartis - Sandoz Business Overview
    Table 58. Novartis - Sandoz Generic Drugs Product
    Table 59. Novartis - Sandoz Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 60. Novartis - Sandoz Recent Development
    Table 61. Mylan Company Details
    Table 62. Mylan Business Overview
    Table 63. Mylan Generic Drugs Product
    Table 64. Mylan Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 65. Mylan Recent Development
    Table 66. Sun Pharmaceutical Company Details
    Table 67. Sun Pharmaceutical Business Overview
    Table 68. Sun Pharmaceutical Generic Drugs Product
    Table 69. Sun Pharmaceutical Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 70. Sun Pharmaceutical Recent Development
    Table 71. Aspen Company Details
    Table 72. Aspen Business Overview
    Table 73. Aspen Generic Drugs Product
    Table 74. Aspen Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 75. Aspen Recent Development
    Table 76. Fresenius Kabi Company Details
    Table 77. Fresenius Kabi Business Overview
    Table 78. Fresenius Kabi Generic Drugs Product
    Table 79. Fresenius Kabi Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 80. Fresenius Kabi Recent Development
    Table 81. Pfizer (Hospira) Company Details
    Table 82. Pfizer (Hospira) Business Overview
    Table 83. Pfizer (Hospira) Generic Drugs Product
    Table 84. Pfizer (Hospira) Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 85. Pfizer (Hospira) Recent Development
    Table 86. Sanofi Company Details
    Table 87. Sanofi Business Overview
    Table 88. Sanofi Generic Drugs Product
    Table 89. Sanofi Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 90. Sanofi Recent Development
    Table 91. Aurobindo Company Details
    Table 92. Aurobindo Business Overview
    Table 93. Aurobindo Generic Drugs Product
    Table 94. Aurobindo Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 95. Aurobindo Recent Development
    Table 96. Lupin Company Details
    Table 97. Lupin Business Overview
    Table 98. Lupin Generic Drugs Product
    Table 99. Lupin Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 100. Lupin Recent Development
    Table 101. Dr. Reddy's Company Details
    Table 102. Dr. Reddy's Business Overview
    Table 103. Dr. Reddy's Generic Drugs Product
    Table 104. Dr. Reddy's Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 105. Dr. Reddy's Recent Development
    Table 106. Apotex Company Details
    Table 107. Apotex Business Overview
    Table 108. Apotex Generic Drugs Product
    Table 109. Apotex Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 110. Apotex Recent Development
    Table 111. Cipla Company Details
    Table 112. Cipla Business Overview
    Table 113. Cipla Generic Drugs Product
    Table 114. Cipla Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 115. Cipla Recent Development
    Table 116. ENDO (Par Pharmaceutical) Company Details
    Table 117. ENDO (Par Pharmaceutical) Business Overview
    Table 118. ENDO (Par Pharmaceutical) Generic Drugs Product
    Table 119. ENDO (Par Pharmaceutical) Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 120. ENDO (Par Pharmaceutical) Recent Development
    Table 121. Stada Arzneimittel Company Details
    Table 122. Stada Arzneimittel Business Overview
    Table 123. Stada Arzneimittel Generic Drugs Product
    Table 124. Stada Arzneimittel Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 125. Stada Arzneimittel Recent Development
    Table 126. Krka Group Company Details
    Table 127. Krka Group Business Overview
    Table 128. Krka Group Generic Drugs Product
    Table 129. Krka Group Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 130. Krka Group Recent Development
    Table 131. Nichi-Iko Pharmaceutical Company Details
    Table 132. Nichi-Iko Pharmaceutical Business Overview
    Table 133. Nichi-Iko Pharmaceutical Generic Drugs Product
    Table 134. Nichi-Iko Pharmaceutical Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 135. Nichi-Iko Pharmaceutical Recent Development
    Table 136. Valeant Company Details
    Table 137. Valeant Business Overview
    Table 138. Valeant Generic Drugs Product
    Table 139. Valeant Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 140. Valeant Recent Development
    Table 141. Zydus Cadila Company Details
    Table 142. Zydus Cadila Business Overview
    Table 143. Zydus Cadila Generic Drugs Product
    Table 144. Zydus Cadila Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 145. Zydus Cadila Recent Development
    Table 146. Hikma Company Details
    Table 147. Hikma Business Overview
    Table 148. Hikma Generic Drugs Product
    Table 149. Hikma Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 150. Hikma Recent Development
    Table 151. Pharmaniaga Berhad Company Details
    Table 152. Pharmaniaga Berhad Business Overview
    Table 153. Pharmaniaga Berhad Generic Drugs Product
    Table 154. Pharmaniaga Berhad Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 155. Pharmaniaga Berhad Recent Development
    Table 156. Hovid Berhad Company Details
    Table 157. Hovid Berhad Business Overview
    Table 158. Hovid Berhad Generic Drugs Product
    Table 159. Hovid Berhad Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 160. Hovid Berhad Recent Development
    Table 161. Duopharma Biotech Company Details
    Table 162. Duopharma Biotech Business Overview
    Table 163. Duopharma Biotech Generic Drugs Product
    Table 164. Duopharma Biotech Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 165. Duopharma Biotech Recent Development
    Table 166. Kotra Pharma Company Details
    Table 167. Kotra Pharma Business Overview
    Table 168. Kotra Pharma Generic Drugs Product
    Table 169. Kotra Pharma Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 170. Kotra Pharma Recent Development
    Table 171. HOE Pharmaceutical Company Details
    Table 172. HOE Pharmaceutical Business Overview
    Table 173. HOE Pharmaceutical Generic Drugs Product
    Table 174. HOE Pharmaceutical Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 175. HOE Pharmaceutical Recent Development
    Table 176. Y.S.P. Industries Company Details
    Table 177. Y.S.P. Industries Business Overview
    Table 178. Y.S.P. Industries Generic Drugs Product
    Table 179. Y.S.P. Industries Revenue in Generic Drugs Business (2018-2023) & (US$ Million)
    Table 180. Y.S.P. Industries Recent Development
    Table 181. Research Programs/Design for This Report
    Table 182. Key Data Information from Secondary Sources
    Table 183. Key Data Information from Primary Sources
List of Figures
    Figure 1. Generic Drugs Product Picture
    Figure 2. Global Generic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Generic Drugs Market Size 2018-2029 (US$ Million)
    Figure 4. India Generic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 5. India Generic Drugs Market Size 2018-2029 (US$ Million)
    Figure 6. India Generic Drugs Market Share in Global 2018-2029
    Figure 7. Generic Drugs Report Years Considered
    Figure 8. Product Picture of Prescription
    Figure 9. Product Picture of Non-Prescription Drugs
    Figure 10. Global Generic Drugs Market Share by Type in 2022 & 2029
    Figure 11. Global Generic Drugs Market Size by Type (2018-2029) & (US$ Million)
    Figure 12. Global Generic Drugs Market Share by Type (2018-2029)
    Figure 13. India Generic Drugs Market Share by Type in 2022 & 2029
    Figure 14. India Generic Drugs Market Size by Type (2018-2029) & (US$ Million)
    Figure 15. India Generic Drugs Market Share by Type (2018-2029)
    Figure 16. Product Picture of Hospital
    Figure 17. Product Picture of Clinic
    Figure 18. Product Picture of Others
    Figure 19. Global Generic Drugs Market Share by Application in 2022 & 2029
    Figure 20. Global Generic Drugs Market Size by Application (2018-2029) & (US$ Million)
    Figure 21. Global Generic Drugs Market Share by Application (2018-2029)
    Figure 22. India Generic Drugs Market Share by Application in 2022 & 2029
    Figure 23. India Generic Drugs Market Size by Application (2018-2029) & (US$ Million)
    Figure 24. India Generic Drugs Market Share by Application (2018-2029)
    Figure 25. The Top 5 and 10 Largest Companies of Generic Drugs in the World: Market Share by Generic Drugs Revenue in 2022
    Figure 26. Global Generic Drugs Market Size Market Share by Region: 2018 VS 2022 VS 2029
    Figure 27. Global Generic Drugs Market Share by Region (2018-2029)
    Figure 28. Americas Generic Drugs Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 29. Americas Generic Drugs Market Share by Type (2018-2029)
    Figure 30. Americas Generic Drugs Market Share by Application (2018-2029)
    Figure 31. United States Generic Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Canada Generic Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Mexico Generic Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Brazil Generic Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 35. EMEA Generic Drugs Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 36. EMEA Generic Drugs Market Share by Type (2018-2029)
    Figure 37. EMEA Generic Drugs Market Share by Application (2018-2029)
    Figure 38. Europe Generic Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Middle East Generic Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Africa Generic Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 41. China Generic Drugs Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 42. China Generic Drugs Market Share by Type (2018-2029)
    Figure 43. China Generic Drugs Market Share by Application (2018-2029)
    Figure 44. APAC Generic Drugs Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 45. APAC Generic Drugs Market Share by Type (2018-2029)
    Figure 46. APAC Generic Drugs Market Share by Application (2018-2029)
    Figure 47. Japan Generic Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 48. South Korea Generic Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 49. China Taiwan Generic Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Southeast Asia Generic Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 51. India Generic Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Teva Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 53. Novartis - Sandoz Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 54. Mylan Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 55. Sun Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 56. Aspen Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 57. Fresenius Kabi Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 58. Pfizer (Hospira) Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 59. Sanofi Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 60. Aurobindo Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 61. Lupin Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 62. Dr. Reddy's Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 63. Apotex Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 64. Cipla Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 65. ENDO (Par Pharmaceutical) Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 66. Stada Arzneimittel Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 67. Krka Group Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 68. Nichi-Iko Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 69. Valeant Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 70. Zydus Cadila Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 71. Hikma Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 72. Pharmaniaga Berhad Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 73. Hovid Berhad Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 74. Duopharma Biotech Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 75. Kotra Pharma Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 76. HOE Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 77. Y.S.P. Industries Revenue Growth Rate in Generic Drugs Business (2018-2023)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$4350

Single User License
Electronic

$6525

Multi User License
Electronic

$8700

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions